Anti-tuberculosis drug induced hepatitis - a Sri Lankan experience

Simple item page
dc.contributor.authorSenaratne, W.V.
dc.contributor.authorPinidiyapathirage, M.J.
dc.contributor.authorPerera, G.A.M.H.E.
dc.contributor.authorWickremasinghe, A.R.
dc.date.accessioned2016-01-14T09:41:46Z
dc.date.available2016-01-14T09:41:46Z
dc.date.issued2006
dc.identifier.citationThe Ceylon Medical Journal, 51(1)pp.9-14
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/21050
dc.publisherElsevier. New Delhi
dc.subjectMedical Sciences
dc.subjectAnti-tuberculosis drug induced hepatitis-AIH
dc.subjectTuberculosis
dc.subjectDrug therapy
dc.subjectDisease management
dc.subjectRisk factors
dc.subjectLiver function
dc.subjectWHO treatment recommendations
dc.subjectSide effects
dc.subjectHepatotoxicity
dc.subjectRifampicin
dc.titleAnti-tuberculosis drug induced hepatitis - a Sri Lankan experience
dc.typeArticle

Files

Collections

The Ceylon Medical Journal